HEALTH-RELATED QUALITY OF LIFE (HRQOL) ANALYSES IN THE AVAGLIO STUDY, A RANDOMIZED, PLACEBO-CONTROLLED PHASE III TRIAL OF BEVACIZUMAB, TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Taphoorn, Martin J. B. ^{[1
,2
]}

Henriksson, Roger ^{[3
,4
]}

Bottomley, Andrew ^{[5
]}

Cloughesy, Timothy ^{[6
]}

Wick, Wolfgang ^{[7
]}

Mason, Warren ^{[8
]}

Saran, Frank ^{[9
]}

Nishikawa, Ryo ^{[10
]}

Ravelo, Arliene ^{[11
]}

Hilton, Magalie ^{[12
]}

Chinot, Olivier L. ^{[13
]}

机构：

[1] Med Ctr Haaglanden, The Hague, Netherlands

[2] VU Univ Med Ctr, The Hague, Netherlands

[3] Reg Canc Ctr Stockholm, Stockholm, Sweden

[4] Umea Univ, Stockholm, Sweden

[5] European Org Res & Treatment Canc EORTC, Qual Life Dept, Brussels, Belgium

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Univ Med Ctr, Heidelberg, Germany

[8] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada

[9] Royal Marsden NHS Fdn Trust, Surrey, England

[10] Saitama Med Univ, Int Med Ctr, Saitama, Japan

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[13] Aix Marseille Univ, CHU Timone, AP HM, Marseille, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：232 / 232

页数：1